Dana Davis
University of Alabama at Birmingham(US)
Publications by Year
Research Areas
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Protease and Inhibitor Mechanisms, Bone Metabolism and Diseases, Peptidase Inhibition and Analysis, Vitamin D Research Studies
Most-Cited Works
- → Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K(2005)138 cited
- → Biochemical Characterization ofS-Nitrosohemoglobin(1999)118 cited
- → Structure-Based Drug Design of RN486, a Potent and Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis(2014)107 cited
- → Design and Synthesis of Tri-Ring P3 Benzamide-Containing Aminonitriles as Potent, Selective, Orally Effective Inhibitors of Cathepsin K(2005)94 cited
- → NOX4 modulates macrophage phenotype and mitochondrial biogenesis in asbestosis(2019)83 cited
- → Cysteine-Rich and Basic Domain HIV-1 Tat Peptides Inhibit Angiogenesis and Induce Endothelial Cell Apoptosis(2001)60 cited
- → 3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P2 elements for selectivity(2003)56 cited
- → Increased flux through the mevalonate pathway mediates fibrotic repair without injury(2019)47 cited
- → Peptides Encoded by Exon 6 of VEGF Inhibit Endothelial Cell Biological Responses and Angiogenesis Induced by VEGF(2001)45 cited
- → Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling(2021)44 cited